Skip to main content
Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
4.980
+0.320 (6.87%)
At close: Dec 20, 2024, 4:00 PM
5.16
+0.18 (3.61%)
After-hours: Dec 20, 2024, 7:59 PM EST

Vivos Therapeutics Revenue

Vivos Therapeutics had revenue of $3.86M in the quarter ending September 30, 2024, with 16.93% growth. This brings the company's revenue in the last twelve months to $14.58M, up 0.54% year-over-year. In the year 2023, Vivos Therapeutics had annual revenue of $13.80M, down -13.87%.

Revenue (ttm)
$14.58M
Revenue Growth
+0.54%
P/S Ratio
1.22
Revenue / Employee
$118,545
Employees
123
Market Cap
24.08M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202313.80M-2.22M-13.87%
Dec 31, 202216.02M-861.00K-5.10%
Dec 31, 202116.89M3.82M29.23%
Dec 31, 202013.07M1.67M14.68%
Dec 31, 201911.39M7.60M200.43%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Allurion Technologies 34.75M
Cara Therapeutics 8.69M
Co-Diagnostics 7.32M
NeuroOne Medical Technologies 3.45M
GeoVax Labs 3.09M
Alterity Therapeutics 2.68M
Longeveron 1.85M
iBio, Inc. 175.00K
Revenue Rankings

VVOS News

More News